Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancerD. Azria, J.P. Gérard, Marta Jarlier et al.|Annals of Oncology|2017Cited by 106